The EGFR signaling pathway maintains aerobic glycolysis in EGFR-mutated lung cancer cells, and EGFR TKIs have an early and profound influence on aerobic glycolysis, as they activate and promote increased oxidative phosphorylation (10), consequently indicating that EGFR mutation status is closely related to glucose metabolism in lung cancer cells. The gene discussed is EGFR; the disease is lung cancer.